abstract |
The invention relates to CCR3 receptor ligands of general formula (I), preferably antagonists thereof, and pharmaceutical compositions comprising them in their salts, solvates and isomers, to general formula (I) And to the preparation of the compounds of general formula (I) and their salts, solvates and isomers. |